生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1161 生物科技

未开盘 10-29 16:00:00

4,543.071

-8.575

-0.19%

最高4,649.741	最低4,531.258	成交量1.62亿
今开4,608.545	昨收4,551.646	日振幅2.60%
总市值0.00	流通市值0.00	总股本0.00
成交额46.60亿	换手率--	流通股本0.00
市净率4.968424	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1161","market":"HK","secType":"PLATE","nameCN":"生物科技","latestPrice":4543.071,"timestamp":1793261299340,"preClose":4551.646,"halted":0,"volume":162083365,"delay":0,"changeRate":-0.001884,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-8.575195,"latestTime":"10-29 16:00:00","open":4608.545,"high":4649.741,"low":4531.2583,"amount":4659658244.5,"amplitude":0.026031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793323800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1793237400000,1793246400000],[1793250000000,1793260800000]],"pbRate":4.968424,"peRate":126.599524,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1161","defaultTab":"news","newsList":[{"id":"2679285027","title":"“基金买手”三季度重仓路径曝光，哪些主动权益基金被大幅增持？","url":"https://stock-news.laohu8.com/highlight/detail?id=2679285027","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679285027?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:00","pubTimestamp":1793282441,"startTime":"0","endTime":"0","summary":"“基金买手”三季度重仓路径曝光，哪些主动权益基金被大幅增持？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610293914932760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610293914932760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0455707207.USD","LU2097828805.USD","LU1997244956.HKD","HK0000181112.HKD","LU1188198961.HKD","LU2097828714.EUR","LU1064131003.USD","LU0039217434.USD","LU2148510915.USD","BK0070","601318","LU0456827905.SGD","LU2495084118.USD","LU0456846285.SGD","SG9999002463.SGD","688266","LU1934453819.USD","01801","LU1064130708.USD","BK0239","BK1161","HK0000181138.USD","LU2097828474.EUR","LU1781817850.SGD","LU1720050803.USD","BK1589","LU2097828631.EUR","LU0405327494.USD","LU1580142542.USD","BK0183","KURE","LU0607220059.USD","LU0463099449.HKD","LU0502904849.HKD","LU2213484517.USD","LU2242644610.SGD","BK0196","LU1655091616.SGD","BK0028","LU1794554557.SGD","IE0005HP3H50.USD","LU0244354667.USD","BK0187","LU2399975544.HKD","LU1831875114.USD","LU0326950275.SGD","LU0051755006.USD","BK0012","LU1997245177.USD","LU0149534421.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679283692","title":"君实生物(01877)前三季度归母净亏损1.49亿元，同比收窄75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679283692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679283692?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:35","pubTimestamp":1793280907,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)发布公告，2026年前三季度，营业收入25.13亿元，同比增长39.18%;归属于上市公司股东的净亏损1.49亿元，同比收窄75%;基本每股亏损0.15元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01877","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679283541","title":"和誉-B(02256)10月29日斥资31.75万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679283541","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679283541?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:30","pubTimestamp":1793280651,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年10月29日该公司斥资31.75万港元回购5万股，回购价格为每股6.325至6.375港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","BK1161","IE00B5MMRT66.SGD","LU2778985437.USD","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU2476274308.USD","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679288936","title":"康诺亚-B(02162.HK)拟根据2022年受限制股份单位计划购买股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2679288936","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679288936?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:14","pubTimestamp":1793279668,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","02162","BK1161","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679407714","title":"维升药业-B(02561)：梁辰获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2679407714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679407714?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:47","pubTimestamp":1793278064,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，陈诗婷女士因其其他工作安排已辞任公司下列职位，自2026年10月29日起生效：公司秘书;法律程序文件代理人;及授权代表。陈女士辞任后，梁辰女士获委任为公司秘书、法律程序文件代理人及授权代表，自2026年10月29日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679402740","title":"思路迪医药股份(01244)：3D189全球关键性III期REGAL试验达到预设事件数","url":"https://stock-news.laohu8.com/highlight/detail?id=2679402740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679402740?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:31","pubTimestamp":1793277097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份 发布与SELLAS Life Sciences Group, Inc. 合作项目3D189的最新重要进展。公司于2020年获得3D189在大中华区的独家开发及商业化权利。截至2026年10月28日，评估GPS用于AML患者的关键性III期REGAL试验已达到预设的80例事件，触发该项研究的最终分析。REGAL试验为一项事件驱动型总生存期研究。在发生第80起事件后，SELLAS 将开展数据库锁定、研究数据揭盲以及主要终点数据统计分析工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515438.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679940212","title":"百奥赛图(02315，688796.SH)前三季度净利大增174%！营收、毛利双提速 规模化盈利能力凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2679940212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679940212?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:25","pubTimestamp":1793276739,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02315","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679404003","title":"圣诺医药-B(02257.HK)授出购股权及受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2679404003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679404003?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:18","pubTimestamp":1793276314,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02257"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679404299","title":"君实生物(01877)：JS207联合JS007用于一线治疗晚期肝细胞癌的III期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2679404299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679404299?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:15","pubTimestamp":1793276140,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物 发布公告，近日，公司产品重组人源化抗 PD-1 和 VEGF 双特异性抗体联合重组人源化抗 CTLA4 单克隆抗体对比特瑞普利单抗联合贝伐珠单抗一线治疗晚期肝细胞癌的有效性和安全性的多中心、随机、对照、开放 III 期临床研究已完成首例患者给药。本研究为 JS207 的首个国内注册临床研究。JS007 是公司自主研发的重组人源化抗 CTLA-4 单克隆抗体注射液，主要用于晚期恶性肿瘤的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDTX","BK1161","BMED","BK1583","IBBQ","BK1515","IBBJ","01877","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679048334","title":"迈威生物：关于召开2026年第三季度业绩说明会的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2679048334","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679048334?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:02","pubTimestamp":1793275320,"startTime":"0","endTime":"0","summary":"    证券日报网讯 10月29日，迈威生物发布公告称，公司计划于2026年11月9日14:00-15:00举行2026年第三季度业绩说明会。 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679405011","title":"第九届进博会前瞻：中国成为全球创新策源地，折射医药创新合作新变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2679405011","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679405011?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:16","pubTimestamp":1793272568,"startTime":"0","endTime":"0","summary":"2026年11月5日~10日，第九届中国国际进口博览会将在上海举行，届时将有162个国家、地区和国际组织参与，4142家境外企业参展，展会整体面积将首次突破44万平方米；其中医疗器械及医药保健、消费品和农食产品三大展区全面扩容。进博会是全球新药进入中国的展示舞台，如今更日益成为中国创新走向世界的起点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610293914579817.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610293914579817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","09939","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403994","title":"迈威生物9月30日股东户数1.86万户，较上期增加0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403994","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679403994?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:58","pubTimestamp":1793271480,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迈威生物披露，截至2026年9月30日公司股东户数为1.86万户，较6月30日增加100.0户，增幅为0.54%。户均持股数量由上期的2.17万股减少至2.15万股，户均持股市值为58.24万元 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679040887","title":"瑞博生物-B(06938)10月29日斥资259.68万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679040887","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679040887?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:57","pubTimestamp":1793271442,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞博生物-B(06938)发布公告，于2026年10月29日斥资259.68万港元回购6万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679474710","title":"ST人福：公司医药研究院已在上海组建专业团队","url":"https://stock-news.laohu8.com/highlight/detail?id=2679474710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679474710?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:18","pubTimestamp":1793269096,"startTime":"0","endTime":"0","summary":"证券之星消息，ST人福(600079)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有在上海设立药物研究院或类似科研机构吗？ST人福回复：答：尊敬的投资者，您好！公司医药研究院已在上海组建专业团队，主要负责商务拓展、临床运营管理等工作。感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900043456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1515","BK0070","BK0012","BK0096","BK0185","09939","600079","BK1574","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679474816","title":"看好公司发展前景 映恩生物-B(09606)董事及高级管理层作出自愿禁售承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2679474816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679474816?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:03","pubTimestamp":1793268205,"startTime":"0","endTime":"0","summary":"映恩生物-B公布，公司董事及高级管理层对公司长期价值及未来发展前景充满信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252160.HKD","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","09606","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679790104","title":"百奥赛图(02315)2026年前三季度跨入“规模化盈利”新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2679790104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679790104?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:45","pubTimestamp":1793267144,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月29日，百奥赛图发布2026年第三季度报告。前三季度，公司实现营业收入 14.03 亿元，同比增长 49.09%；毛利 10.95 亿元，同比增长 55.35%；归母净利润 3.12 亿元，同比增长 173.77%。公司已从“实现盈利”跨入“规模化盈利”的阶段。百奥赛图前三季度累计经营活动净现金流 4.22 亿元，高于同期归母净利润 3.12 亿元，并已超过2025年全年水平。报告期内，海门新动物房陆续投产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK0216","BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679799514","title":"歌礼制药-B(01672)10月29日耗资约52.54万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679799514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679799514?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:35","pubTimestamp":1793266559,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)公布，2026年10月29日耗资约52.54万港元回购10万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","01477","BK1191","BK1161","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679479959","title":"歌礼制药-B(01672.HK)10月29日耗资约52.54万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679479959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679479959?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:35","pubTimestamp":1793266559,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","01672","BK1191","01477","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679475841","title":"昊海生物科技(06826)10月29日斥资27.11万港元回购1.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679475841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679475841?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:57","pubTimestamp":1793264260,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年10月29日，该公司斥资27.11万港元回购1.69万股股份，每股回购价16-16.1港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679473495","title":"10月29日泽璟制药跌6.43%，汇添富创新医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679473495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679473495?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:47","pubTimestamp":1793263678,"startTime":"0","endTime":"0","summary":"证券之星消息，10月29日泽璟制药跌6.43%创60日新低，收盘报84.2元，换手率2.37%，成交量6.28万手，成交额5.35亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共75家，其中持有数量最多的公募基金为汇添富基金的汇添富创新医药混合A。汇添富创新医药混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900040733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1515","159938","BK1161","BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":-0.0638},{"period":"3month","weight":-0.113},{"period":"6month","weight":-0.1093},{"period":"1year","weight":-0.1286},{"period":"ytd","weight":-0.1042}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1161","nameEN":"BK1161"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK1161,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}